1.
Rossato P, Federti E, Matte A, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Andolfo I, Iolascon A, Rottensteiner H, Gritsch H, Scheiflinger F, Hoellriegl W, Franceschi LD. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. haematol [Internet]. 2022Apr.21 [cited 2022Dec.6];107(11):2650-6. Available from: https://haematologica.org/article/view/haematol.2021.280233